Your browser doesn't support javascript.
loading
Case Report: Refractory Cytopenia With a Switch From a Transient Monosomy 7 to a Disease-Ameliorating del(20q) in a NHEJ1-Deficient Long-term Survivor.
Poyer, Fiona; Jimenez Heredia, Raúl; Novak, Wolfgang; Zeitlhofer, Petra; Nebral, Karin; Dworzak, Michael N; Haas, Oskar A; Boztug, Kaan; Kager, Leo.
Afiliação
  • Poyer F; St. Anna Children's Hospital, Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.
  • Jimenez Heredia R; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.
  • Novak W; Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, Vienna, Austria.
  • Zeitlhofer P; Center for Molecular Medicine Center for Molecular Medicine (CeMM) Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
  • Nebral K; St. Anna Children's Hospital, Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.
  • Dworzak MN; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.
  • Haas OA; Labdia, Labordiagnostik, Vienna, Austria.
  • Boztug K; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.
  • Kager L; Labdia, Labordiagnostik, Vienna, Austria.
Front Immunol ; 13: 869047, 2022.
Article em En | MEDLINE | ID: mdl-35812385
ABSTRACT
We report the case of a male Pakistani patient with a pathogenic homozygous loss of function variant in the non-homologous end-joining factor 1 (NHEJ1) gene. The growth retarded and microcephalic boy with clinodactyly of both hands and hyperpigmentation of the skin suffered from recurrent respiratory infections. He was five and a half years old when he came to our attention with refractory cytopenia and monosomy 7. Hematopoietic stem cell transplantation was considered but not feasible because there was no suitable donor available. Monosomy 7 was not detected anymore in subsequent bone marrow biopsies that were repeated in yearly intervals. Instead, seven and a half years later, a novel clone with a del(20q) appeared and steadily increased thereafter. In parallel, the patient's blood count, which had remained stable for over 20 years without necessitating any specific therapeutic interventions, improved gradually and the erythropoiesis-associated dysplasia resolved.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Transplante de Células-Tronco Hematopoéticas Limite: Child, preschool / Humans / Male Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Áustria

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Transplante de Células-Tronco Hematopoéticas Limite: Child, preschool / Humans / Male Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Áustria
...